Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evelyne Kohli

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Virologie (Montrouge, France)|September 24, 2022
[Rotavirus vaccines]Evelyne Kohli, Frédéric Huet
Frontiers in Medicine|November 3, 2022
RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislationMathieu Guerriaud, Evelyne Kohli
Current Opinion in Immunology|August 7, 2025
Intracellular complement in monocytes and macrophages: emerging rolesValentin Baverel, Carmen Garrido, Evelyne Kohli
Cell Death Discovery|December 15, 2025
The chaperone GRP94 interacts with the proprotein convertase furin and regulates TGF-beta maturation in human primary M2 macrophagesValentin Baverel, Fangmin Wang, Carmen Garrido, et al.
Journal of Clinical Microbiology|August 9, 2003
Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in FranceBéatrice Nicollier-Jamot, Valérie Pico, Pierre Pothier, et al.
Microbial Pathogenesis|August 31, 2015
B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2/6-VLP specific antibody responses and induce a Th17-like response after intrarectal immunizationFatou Thiam, Annie Charpilienne, Didier Poncet, et al.
Gene Therapy|March 1, 2024
Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidateMathieu Guerriaud, Cyril Poupet, Zineb Lakhrif, et al.
Vaccine|March 9, 2004
Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responsesBéatrice Nicollier-Jamot, Agathe Ogier, Lionel Piroth, et al.
Vaccines|October 26, 2021
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis PatientYves Michiels, Nadhira Houhou-Fidouh, Gilles Collin, et al.
Biology|September 28, 2021
GARP: A Key Target to Evaluate Tumor Immunosuppressive MicroenvironmentAlexanne Bouchard, Bertrand Collin, Carmen Garrido, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Virologie (Montrouge, France)|September 24, 2022
[Rotavirus vaccines]Evelyne Kohli, Frédéric Huet
Frontiers in Medicine|November 3, 2022
RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislationMathieu Guerriaud, Evelyne Kohli
Current Opinion in Immunology|August 7, 2025
Intracellular complement in monocytes and macrophages: emerging rolesValentin Baverel, Carmen Garrido, Evelyne Kohli
Cell Death Discovery|December 15, 2025
The chaperone GRP94 interacts with the proprotein convertase furin and regulates TGF-beta maturation in human primary M2 macrophagesValentin Baverel, Fangmin Wang, Carmen Garrido, et al.
Journal of Clinical Microbiology|August 9, 2003
Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in FranceBéatrice Nicollier-Jamot, Valérie Pico, Pierre Pothier, et al.
Microbial Pathogenesis|August 31, 2015
B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2/6-VLP specific antibody responses and induce a Th17-like response after intrarectal immunizationFatou Thiam, Annie Charpilienne, Didier Poncet, et al.
Gene Therapy|March 1, 2024
Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidateMathieu Guerriaud, Cyril Poupet, Zineb Lakhrif, et al.
Vaccine|March 9, 2004
Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responsesBéatrice Nicollier-Jamot, Agathe Ogier, Lionel Piroth, et al.
Vaccines|October 26, 2021
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis PatientYves Michiels, Nadhira Houhou-Fidouh, Gilles Collin, et al.
Biology|September 28, 2021
GARP: A Key Target to Evaluate Tumor Immunosuppressive MicroenvironmentAlexanne Bouchard, Bertrand Collin, Carmen Garrido, et al.
Pageof 4